Catalent, Inc. (CTLT)
Dec 18, 2024 - CTLT was delisted (reason: acquired by Novo Holdings)
63.48
0.00 (0.00%)
Inactive · Last trade price
on Dec 17, 2024
Catalent Employees
Catalent had 17,800 employees as of June 30, 2023. The number of employees decreased by 1,200 or -6.32% compared to the previous year.
Employees
17,800
Change (1Y)
-1,200
Growth (1Y)
-6.32%
Revenue / Employee
$248,427
Profits / Employee
-$23,202
Market Cap
11.52B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 17,800 | -1,200 | -6.32% |
Jun 30, 2022 | 19,000 | 1,700 | 9.83% |
Jun 30, 2021 | 17,300 | 3,400 | 24.46% |
Jun 30, 2020 | 13,900 | 1,600 | 13.01% |
Jun 30, 2019 | 12,300 | 1,600 | 14.95% |
Jun 30, 2018 | 10,700 | -100 | -0.93% |
Jun 30, 2017 | 10,800 | 1,600 | 17.39% |
Jun 30, 2016 | 9,200 | 500 | 5.75% |
Jun 30, 2015 | 8,700 | 400 | 4.82% |
Jun 30, 2014 | 8,300 | 0 | - |
Sep 30, 2013 | 8,300 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
CTLT News
- 4 weeks ago - Novo Holdings looks to double Catalent size with eye on Trump US manufacturing focus - Reuters
- 2 months ago - Lennox International Set to Join S&P 500 and BILL Holdings to Join S&P MidCap 400 - PRNewsWire
- 2 months ago - Novo Holdings completes $16.5 bln takeover of Catalent - Reuters
- 2 months ago - Novo Holdings Completes Acquisition of Catalent - Business Wire
- 2 months ago - Regulatory conditions on Novo Holdings' $16.5 bln Catalent deal fulfilled, companies say - Reuters
- 2 months ago - Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close - GlobeNewsWire
- 2 months ago - Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction - Business Wire
- 2 months ago - The European Commission approves the acquisition of Catalent by Novo Holdings and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings - GlobeNewsWire